Legend Biotech to Host Virtual Investor KOL Event Reviewing Latest CARTITUDE-1 Data from the 62nd American Society of Hematology (ASH) Annual Meeting

SOMERSET, N.J.–(BUSINESS WIRE)–Nov 24, 2020–

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech) today announced that it will host a virtual Key Opinion Leader (KOL) event on Monday, December 7 at 7 pm ET highlighting the latest data from the Phase 1b/2 CARTITUDE-1 study ( NCT03548207 ) of ciltacabtagene autoleucel (cilta-cel), an investigational BCMA-directed CAR-T cell therapy being studied for the treatment of patients with relapsed or refractory multiple myeloma. This will follow the oral presentation of the study results ( Abstract #177 ) at the 2020 ASH Annual Meeting.

Intended for investors and other interested audiences, the event includes presentations by Ying Huang, PhD, CEO and CFO of Legend Biotech, along with the following leading professionals in hematology and oncology:

  • Sundar Jagannath, MD, Professor of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine; Director, Multiple Myeloma Program at Mount Sinai Hospital.
  • Thomas G. Martin, MD, Clinical Professor of
Read More

Health care is going digital and that could make it ‘almost free,’ says tech investor Tim Draper

  • In future, artificial intelligence will help to diagnose patients and develop the medicine required at “very low costs,” says venture capitalist Tim Draper.
  • He said medical costs have been “crazy high” for many years. “Finally, we’re going to have a way of doing health care a lot cheaper.”
  • Ibrahim Ajami of Mubadala, said the coronavirus has led to “probably the most significant acceleration of technology … we will witness in our lives” and that the role of technology in health care has changed.



a group of people in a room: People wait in line to get a 15-minute rapid Covid-19 test on November 24, 2020 in Madison, Wisconsin.


© Provided by CNBC
People wait in line to get a 15-minute rapid Covid-19 test on November 24, 2020 in Madison, Wisconsin.

The use of technology is going to make health care “almost free around the world,” according to venture capitalist Tim Draper.

“Health care is completely going digital,” he told CNBC’s Dan Murphy during a panel discussion at FinTech Abu Dhabi, which was held virtually this

Read More

Tech investor Tim Draper says digital health care will be ‘almost free’

People wait in line to get a 15-minute rapid Covid-19 test on November 24, 2020 in Madison, Wisconsin.

Andy Manis | Getty Images News | Getty Images

The use of technology is going to make health care “almost free around the world,” according to venture capitalist Tim Draper.

“Health care is completely going digital,” he told CNBC’s Dan Murphy during a panel discussion at FinTech Abu Dhabi, which was held virtually this year.

“That’s going to create health care that is almost free around the world,” said the founder and managing partner of early-stage venture capital firm, Draper Associates.

Ibrahim Ajami of Mubadala Investment Company, one of Abu Dhabi’s sovereign wealth funds, said the coronavirus has led to “probably the most significant acceleration of technology … we will witness in our lives.” The role of technology in health care has changed, he said.

“Everything from clinical trials to drug discovery,

Read More

Legend Biotech to Host Virtual Investor KOL Event Reviewing Latest CARTITUDE-1 Data from the 62nd American Society of Hematology (ASH) Annual Meeting – Press Release

SOMERSET, N.J.–(Business Wire)–Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech) today announced that it will host a virtual Key Opinion Leader (KOL) event on Monday, December 7 at 7 pm ET highlighting the latest data from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) of ciltacabtagene autoleucel (cilta-cel), an investigational BCMA-directed CAR-T cell therapy being studied for the treatment of patients with relapsed or refractory multiple myeloma. This will follow the oral presentation of the study results (Abstract #177) at the 2020 ASH Annual Meeting.

Intended for investors and other interested audiences, the event includes presentations by Ying Huang, PhD, CEO and CFO of Legend Biotech, along with the following leading professionals in hematology and oncology:

  • Sundar Jagannath, MD, Professor of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine; Director, Multiple Myeloma Program at Mount Sinai Hospital.
  • Thomas G. Martin, MD, Clinical Professor of Medicine, Adult Leukemia and Bone Marrow Transplantation
Read More

Align Technology Hosts 2020 Virtual Investor Day

The MarketWatch News Department was not involved in the creation of this content.

  • Huge global market opportunity of 15M annual orthodontic case starts with an incremental 500 million potential through Align’s doctor-driven model and its digital platform
  • Strategic priorities drive Align’s 5-year revenue CAGR of more than 20%
  • iTero scanner installed base of more than 35K enables more than 1M scans per month and drives Invisalign adoption

SAN JOSE, Calif., Nov 23, 2020 (GLOBE NEWSWIRE via COMTEX) —
SAN JOSE, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) — Align Technology, Inc. (NASDAQ: ALGN) announced that it is hosting a Virtual Investor Day today focused on the Align digital platform that is enabling doctors to deliver the benefits of digital orthodontics to more than 9 million patients and counting. Align Technology CEO Joe Hogan will share Align’s vision and strategy of successful disruptive innovation that is accelerating a wave of digital orthodontics,

Read More

Align Technology Hosts 2020 Virtual Investor Day | Money

After registering, you will receive a confirmation email with information about how to join the webinar.

Q&A session attendees will be able to submit written questions via the Q&A window.

Forward Looking Statement

This press release includes forward looking statements that involve a number of risks and uncertainties. Words such as “believes,” “anticipates,” “plans,” “intends,” “expects,” “seeks,” “estimates,” and similar expressions are intended to identify forward-looking statements, but other statements that are not historical facts may also be deemed to be forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the markets for Align’s products, its beliefs concerning the digital transformation of dentistry and Align’s strategic priorities, its business momentum, products and product mix, the COVID-19 pandemic and its impacts on Align’s business and results of operations, Align’s expectations for digital adoption in dentistry and

Read More

Global and local supply chains must split and technology will play a bigger role, investor says

  • There will need to be “self-contained” local ecosystems and a “highly engaged, interlocked” global supply chain, said Min Wanli of North Summit Capital.
  • He also said the pandemic has accelerated the trend of streamlining supply chains and discussed how technology would play a part in that process.



a man wearing a suit and tie: CEO and Founder of North Summit Capital Min Wanli speaks during Day 2 of CNBC East Tech West on November 18, 2020 in Nansha, Guangzhou, China.


© Provided by CNBC
CEO and Founder of North Summit Capital Min Wanli speaks during Day 2 of CNBC East Tech West on November 18, 2020 in Nansha, Guangzhou, China.

A split between global and local supply chains will be important in the event of another crisis like the global pandemic, said the chief executive and founder of investment firm North Summit Capital.

Loading...

Load Error

“I believe there’s a bifurcation of the global supply chain into global and local,” said Min Wanli of technology-focused North Summit Capital.

A supply chain is a network between a company and its suppliers to produce and distribute

Read More

Palo Alto Networks to Present at Upcoming Investor Events

SANTA CLARA, Calif., Nov. 13, 2020 /PRNewswire/ — Palo Alto Networks (NYSE: PANW), the global cybersecurity leader, announced today that members of its management team will be presenting at the following financial community events:

Wells Fargo Technology, Media, & Telecommunications Summit 2020
Tuesday, December 1, 2020
1:00 p.m. PDT

Barclays Global Technology, Media and Telecommunications Conference
Thursday, December 10, 2020
9:00 a.m. PDT

Additional information about upcoming investor event participation and a live audio webcast of each presentation will be accessible from the “Investors” section of the Palo Alto Networks website at investors.paloaltonetworks.com.

ABOUT PALO ALTO NETWORKS
Palo Alto Networks, the global cybersecurity leader, is shaping the cloud-centric future with technology that is transforming the way people and organizations operate. Our mission is to be the cybersecurity partner of choice, protecting our digital way of life. We help address the world’s greatest security challenges with continuous innovation that seizes

Read More

French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipeline



logo: FILE PHOTO: Sanofi logo is seen in Paris Reuters


© Reuters
FILE PHOTO: Sanofi logo is seen in Paris Reuters

  • Sanofi, one of the world’s biggest pharmaceutical companies, has invested €50 million in new French-based VC Jeito Capital.
  • Jeito CEO Rafaèle Tordjman, managing director of innovation at Jeito Capital, spoke with Business Insider about how the fund plans to invest the money.
  • Jeito’s first fund has already invested in two companies, with plans to invest in a further 4-5 in the next year.
  • Visit Business Insider’s homepage for more stories.

France’s Sanofi, one of the world’s biggest pharmaceutical companies, has invested €50 million ($59 million) in venture capital firm Jeito Capital, Jeito CEO Rafaèle Tordjman said on Friday.

Loading...

Load Error

Jeito Capital, a Paris-based venture capital firm, plans to invest in biopharma and biotech companies across all different funding stages. Sanofi is the world’s fifth-largest drugmaker by prescription sales. Its better known over-the-counter brands include anti-acid products such as

Read More

NYC-based 2048 Ventures taps Seattle investor Minda Brusse to target Pacific Northwest startups

Minda Brusse.

Another out-of-town firm has its eyes on the Seattle startup scene.

New York City-based 2048 Ventures has hired Minda Brusse as a venture partner. Brusse will help the firm find pre-seed investments in Seattle and Portland.

Brusse will continue in her role at First Row Partners, the Seattle-based venture capital firm she co-founded last year with Yoko Okano.

2048 Ventures launched last year with a $27 million fund. It has already backed 29 companies across 13 geographies. The firm invests across various industries including digital health, genomics, artificial intelligence, machine learning, robotics, and more.

“2048 Ventures is the earliest stage, high conviction, lead investor,” Brusse said. “We aim to lead pre-seed and early seed rounds in companies that are differentiated through technology and data.”

Brusse said her new gig compliments the work she does at First Row Partners.

“The roles overlap a lot for sourcing deals at pre-seed

Read More